Our observations are consistent with previous reports of elevated Gal-9 expression in CLL B lymphocytes, which aligns with findings from Wdowiak et al., who reported increased levels of soluble Gal-9 in the serum of CLL patients [49]. The gene discussed is LGALS9; the disease is B-cell chronic lymphocytic leukemia.